ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

OCX Oncocyte Corporation

2.66
0.00 (0.00%)
Pre Mercado
Última actualización: 06:00:10
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Oncocyte Corporation OCX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 2.66 06:00:10
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.66
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
12/4/202405:00GLOBEOncocyte Reports Full Year 2023 Financial Results
11/4/202420:46GLOBEOncocyte Corporation Announces $15.8 Million Private..
11/4/202416:30GLOBEOncocyte and Bio-Rad Partner on Global Launch of Transplant..
09/4/202415:05GLOBEOncocyte to Announce Fourth Quarter and Full Year 2024..
23/1/202415:39EDGAR2Form 8-K - Current report
16/1/202407:00GLOBEOncocyte to Present at the Sequire Investor Summit in Puerto..
06/12/202307:00GLOBEOncocyte Begins FDA Submissions Process for VitaGraft..
09/11/202316:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:05EDGAR2Form 8-K - Current report
09/11/202306:00GLOBEOncocyte Reports Third Quarter 2023 Financial Results
03/11/202307:30GLOBEOncocyte to Announce Third Quarter 2023 Financial Results
12/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202315:48EDGAR2Form 8-K/A - Current report: [Amend]
05/10/202315:05EDGAR2Form 8-K - Current report
20/9/202308:00EDGAR2Form 8-K - Current report
28/8/202315:05EDGAR2Form 8-K - Current report
17/8/202317:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202315:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:05EDGAR2Form 8-K - Current report
25/7/202308:08GLOBEVitaGraft Kidney Expands Utility in Recurrent Primary..
24/7/202316:28EDGAR2Form 8-K - Current report
24/7/202312:35GLOBEOncocyte Announces 1-For-20 Reverse Stock Split
21/7/202316:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/7/202305:03EDGAR2Form 8-K - Current report
10/7/202310:20EDGAR2Form DEF 14A - Other definitive proxy statements
03/7/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202315:14EDGAR2Form PRE 14A - Other preliminary proxy statements
29/6/202315:05EDGAR2Form 8-K - Current report
27/6/202307:30GLOBEOncocyte Begins Manufacturing Transplant Blood Test
11/5/202307:00GLOBEOncocyte Reports First Quarter 2023 Financial Results

Su Consulta Reciente

Delayed Upgrade Clock